‘Going Viral: Discussions on New and Old Foes’
What makes you optimistic? Community and Connectedness
In this conversation, Dr Sarah Garner will share the cutting edge research on COVID treatments and cures as well as other exciting research on illnesses like HIV.
The panel chatting to Sarah includes Professor Catherine Bennett, inaugural chair in Epidemiology, and Head of the Deakin University School of Health and Social Development from 2010 to 2019; Associate Professor Paul Cooper; and Victor Perton. The webinar is designed to answer your questions.
Dr Sarah Garner MBBS BMedSci (Hons) FRCPA FRACP is undertaking her PhD at Walter and Eliza Hall Institute of Medical Research (WEHI).
WEHI researchers are working towards better approaches to diagnose, treat and prevent the spread of viruses, both to address the current COVID-19 global outbreak as well as in preparedness for likely future pandemics.
We’ll be talking COVID-19 and HIV, exciting research and optimism.
What don't we know?
Sarah is an Infectious Diseases Physician at Eastern Infectious Diseases and Travel Medicine (EIDTM) and Monash Health and also a Medical Microbiologist with Dorevitch Pathology. She sees COVID as a physician, a pathologist and a researcher at the cutting-edge.
Sarah's PhD research is tackling the intricate pathways of HIV.
Her PhD research, supervised by Professor Marc Pellegrini and Dr Cody Allison, is looking at how the virus hides itself in the body.
“My goal is to harness the pathways that exist in our cells already to try and clear the virus from these hiding places,” Sarah explained.
“So you’ll often find me in the high containment laboratory working on the virus, where I isolate and analyse different types of cells to understand how they respond to viral infection.”
“WEHI is a wonderful place to be a student. There is so much support, and the Institute’s facilities are world-class. I feel fortunate to have access to the resources we have. I interact with laboratory heads, postdocs and other students who are very approachable and dedicated, and all of our research benefits from extensive collaboration networks.”
Clinician PhD study at the Institute has provided Sarah with a strong foundation to focus on the big picture.
“I am passionate about research outcomes and world-class healthcare for all people, regardless of income, gender, ethnic background or sexuality,” Sarah said.